<DOC>
	<DOCNO>NCT01845493</DOCNO>
	<brief_summary>The investigator perform pilot study daily treatment oral sulforaphane ( SFN ) 3 day determine Nuclear factor ( erythroid-derived 2 ) -like 2 ( NRF2 ) induction possible supplementation regimen individual allergic asthma .</brief_summary>
	<brief_title>Sulforaphane Supplementation Atopic Asthmatics</brief_title>
	<detailed_description>This pilot study examine oral SFN supplementation induce NRF2 NRF2-dependent phase II enzymes nasal epithelial cell allergic asthmatic . Subjects receive SFN-rich broccosprout homogenate preparation alfalfa sprout homogenate ( placebo ) crossover fashion . mRNA level NRF2 NRF2-dependent phase II enzyme compare active placebo period .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Sulforafan</mesh_term>
	<criteria>1 . Age 1850 gender 2 . History episodic wheezing , chest tightness , shortness breath age 6 year consistent asthma , physician diagnose asthma age 6 year . 3 . AND : Positive methacholine test . A positive test define provocative concentration methacholine 10 mg/ml less produce 20 % fall FEV1 ( PC20 methacholine ) . Methacholine challenge separate screening protocol ( 980799 ) , venue accept . 4 . OR : Pre post bronchodilator FEV1 improvement 12 % 4 puff albuterol inhaler . 5 . FEV1 least 80 % predict FEV1/FVC ratio least .70 ( without use bronchodilating medication 12 hour ) , consistent lung function person mild episodic mild persistent asthma ( NHANES III predict set ) . 6 . Allergic sensitization least one follow allergen preparation : ( House Dust Mite f , House dust mite p , Cockroach , Tree mix , Grass Mix , Weed Mix , Mold Mix 1 , Mold Mix 2 , Rat , Mouse , Guinea Pig , Rabbit , Cat Dog ) confirm positive immediate skin test response separate screening protocol . Proof allergy venue , include ImmunoCAP test medical workup , provide subject , accept . 7 . Oxygen saturation &gt; 94 % normal blood pressure ( Systolic 150 90 , Diastolic 9060 mm Hg ) 8 . Willing provide information regard health history habit cigarette smoke exposure ; 9 . Willing avoid antioxidant vitamins cruciferous vegetable well juices/drinks add vitamin supplement 2 day prior baseline screen visit throughout initial dosing period . 10 . Subjects must willing avoid antihistamine use 4 day prior session NSAIDs 7 day prior session . Nasal steroid must hold 2 week prior session . 1 . Medical history underlie health problem preclude participation protocol per study physician ; 2 . Current nutritional disorder anorexia , bulimia , irritable bowel syndrome , Crohn 's disease etc ; 3 . Use oral corticosteroid within past 4 week ; 4 . Presence upper low respiratory tract infection treatment antibiotic within previous 4 week ; 5 . Pregnancy determine menstrual history urine pregnancy test ; 6 . Current smoker exclude . Anyone smoke history &gt; 0.5 pack year and/or &gt; 1 pack per month also exclude . 7 . History bleed disorder ; 8 . Recent nasal surgery ( 6 month ) . If subject nasal surgery 6 month 5 year , study physician visualize area prior biopsy evaluate suitability nose procedure . 9 . History intolerance aversion broccoli 10 . Unable withhold nasal steroid 2 week session . These subject may defer allergy season .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>asthma</keyword>
	<keyword>Asthmatics</keyword>
	<keyword>allergic</keyword>
	<keyword>allergy</keyword>
</DOC>